BioCentury
ARTICLE | Financial News

Radius prices $300M notes offering

August 11, 2017 7:05 PM UTC

On Aug. 8, Radius Health Inc. (NASDAQ:RDUS) raised $300 million through the sale of 3% senior convertible notes due Sept.1, 2024. The notes have an initial conversion price of $48.81, which is a 21% premium to the company's close of $40.46 on Aug. 7, when it proposed the offering after market hours. JPMorgan, Morgan Stanley, Citigroup and Leerink are underwriters...

BCIQ Company Profiles

Radius Health Inc.